Pharmabiz12m
Zimmer Biomet to buy medical device company, Paragon 28 for $1.2 billion
Zimmer Biomet to buy medical device company, Paragon 28 for $1.2 billion: Warsaw, Indiana Thursday, January 30, 2025, 14:00 Hrs [IST] Zimmer Biomet Holdings, Inc., a global medica ...
Pharmabiz1h
WHO statement on potential global threat to people living with HIV
The World Health Organization (WHO) expresses deep concern about the implications of the immediate funding pause for HIV programmes in low- and middle-income countries. These programmes provide access ...
Pharmabiz2h
Polarean Imaging & SimonMed Imaging collaborate to advance lung imaging innovation
Polarean Imaging & SimonMed Imaging collaborate to advance lung imaging innovation: Durham, North Carolina Thursday, January 30, 2025, 12:00 Hrs [IST] Polarean Imaging plc, a comm ...
Pharmabiz3h
Scientists at KL Krems sheds light on how a2d protein mutations affect neurodevelopmental processes
Scientists at KL Krems sheds light on how a2d protein mutations affect neurodevelopmental processes: Krems, Austria Thursday, January 30, 2025, 11:00 Hrs [IST] A recent study has ...
Pharmabiz4h
C2 PHARMA receives CEP approval from EDQM for oxybuprocaine hydrochloride
C2 PHARMA receives CEP approval from EDQM for oxybuprocaine hydrochloride: Cork, Ireland Thursday, January 30, 2025, 10:00 Hrs [IST] C2 PHARMA, the global leader in manufacturing ...
Pharmabiz6h
Round Table Conference on RWE brings together eminent experts from India & Europe to discuss future of RWE
Shardul Nautiyal, Mumbai Thursday, January 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz6h
Kerala, Karnataka & UP report almost 50% of sales of Jan Aushadhi Kendras in five years
Kerala, Karnataka & UP report almost 50% of sales of Jan Aushadhi Kendras in five years: Gireesh Babu, New Delhi Thursday, January 30, 2025, 08:00 Hrs [IST] Kerala, Karnataka and ...
Pharmabiz6h
Indian healthcare sees AI & VR to reshape how medical treatment is accessed and delivered
Indian healthcare sees AI & VR to reshape how medical treatment is accessed and delivered: Nandita Vijayasimha, Bengaluru Thursday, January 30, 2025, 08:00 Hrs [IST] The Indian he ...
Pharmabiz6h
Dissenting group in TNCDA forms 13 district committees with majority of retailers
Dissenting group in TNCDA forms 13 district committees with majority of retailers: Peethaambaran Kunnathoor, Chennai Thursday, January 30, 2025, 08:00 Hrs [IST] Amid the stand-off ...
Pharmabiz6h
DGFT amends HBP-2023 to implement eCoO system to streamline export documentation process
DGFT amends HBP-2023 to implement eCoO system to streamline export documentation process: Shardul Nautiyal, Mumbai Thursday, January 30, 2025, 08:00 Hrs [IST] In a significant mov ...
Pharmabiz20h
Neurocrine Biosciences begins phase 3 registrational study of osavampator as an adjunctive therapy to treat major depressive disorder
Neurocrine Biosciences begins phase 3 registrational study of osavampator as an adjunctive therapy to treat major depressive disorder: San Diego Wednesday, January 29, 2025, 18:00 ...
Pharmabiz21h
GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP
GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...